Skip to Main Content
Legislation Search

H.R. 4395: Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025

The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025 aims to address the significant health issue of uterine fibroids, which affect a large number of women in the United States. Here is a summary of the main components of the bill:

Findings

The bill outlines several important findings regarding uterine fibroids:

  • Between 20% to 50% of women of reproductive age are estimated to have uterine fibroids, with many not diagnosed.
  • Approximately 26 million women in the U.S. in the age range of 15 to 50 are affected, with about 15 million experiencing symptoms.
  • Symptomatic fibroids can cause a variety of health issues, including pelvic pain, heavy menstrual bleeding, infertility, and complications during pregnancy.
  • Many women with fibroids experience a significant decline in quality of life, affecting their ability to work and care for their families.
  • The current medical understanding and data related to fibroids is inadequate, particularly regarding the experiences of minority groups.
  • Research funding for uterine fibroids is low compared to the prevalence and economic impact of the condition.

Research on Uterine Fibroids

The bill mandates the Secretary of Health and Human Services to:

  • Expand and enhance research programs specifically focused on uterine fibroids.
  • Coordinate this research with relevant agencies and institutes.
  • Authorize $30 million per year from fiscal years 2026 to 2030 for these research initiatives.

Research on Medicaid Coverage

The bill requires the establishment of a research database to:

  • Collect data on treatments provided to Medicaid recipients with uterine fibroids.
  • Prepare a report within two years of the bill's enactment detailing federal and state expenditures on these services.

Education and Information Dissemination

The Secretary is tasked with developing a public education program that includes:

  • Information on the prevalence and incidence of uterine fibroids, particularly in minority populations.
  • Awareness of the elevated risks faced by these populations.
  • Available treatment options, focusing on non-hysterectomy methods where appropriate.

This information may be disseminated directly or through partnerships with various organizations.

Information for Health Care Providers

The bill mandates education for health care providers about:

  • Evidence-based care options for managing fibroids.
  • Specific attention to minority populations who may be at heightened risk.

Funding as necessary for these educational programs is authorized for fiscal years 2026 through 2030.

Definition of Minority Individuals

The bill provides a definition of "minority individuals" as those belonging to racial and ethnic minority groups as defined in existing public health legislation.

Relevant Companies

None found.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

50 bill sponsors

Actions

2 actions

Date Action
Jul. 15, 2025 Introduced in House
Jul. 15, 2025 Referred to the House Committee on Energy and Commerce.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

No relevant congressional stock trades found.